Phase I Study of Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Subjects With Metastatic Cancer

This study has been completed.
VioQuest Pharmaceuticals
Information provided by (Responsible Party):
Prescient Therapeutics, Ltd. Identifier:
First received: August 10, 2006
Last updated: May 21, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2010
  Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)